CHRISTOPHER EDWARDS: Open Payments
NPI 1023886397 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 63 payments from 20 companies in 2025. Trend: 2023 $232 · 2024 $626 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $396 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Amgen Inc. | 4 | $64 |
| Novo Nordisk Inc | 4 | $64 |
| Lilly USA, LLC | 4 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: VRAYLAR, FANAPT, QULIPTA, TRELEGY ELLIPTA, UBRELVY, EVENITY, Ozempic, MOUNJARO.
Industry payments across ID — which companies pay providers there.
